Cargando…

Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer

BACKGROUND: Mammary cancer has a high incidence in canines and is an excellent model of spontaneous carcinogenesis. Molecular iodine (I(2)) exerts antineoplastic effects on different cancer cells activating re-differentiation pathways. In co-administration with anthracyclines, I(2) impairs chemoresi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zambrano-Estrada, Xóchitl, Landaverde-Quiroz, Brianda, Dueñas-Bocanegra, Andrés A., De Paz-Campos, Marco A., Hernández-Alberto, Gerardo, Solorio-Perusquia, Benjamín, Trejo-Mandujano, Manuel, Pérez-Guerrero, Laura, Delgado-González, Evangelina, Anguiano, Brenda, Aceves, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848438/ https://www.ncbi.nlm.nih.gov/pubmed/29530037 http://dx.doi.org/10.1186/s12917-018-1411-6

Ejemplares similares

Molecular iodine exerts antineoplastic effects by diminishing proliferation and invasive potential and activating the immune response in mammary cancer xenografts
por: Mendieta, Irasema, et al.
Publicado: (2019)

Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection
por: Alfaro, Yunuen, et al.
Publicado: (2013)

Molecular Iodine Has Extrathyroidal Effects as an Antioxidant, Differentiator, and Immunomodulator
por: Aceves, Carmen, et al.
Publicado: (2021)

Molecular Iodine/Cyclophosphamide Synergism on Chemoresistant Neuroblastoma Models
por: Álvarez-León, Winniberg, et al.
Publicado: (2021)

Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study
por: Moreno-Vega, Aura, et al.
Publicado: (2019)

Molecular Iodine Supplement Prevents Streptozotocin-Induced Pancreatic Alterations in Mice
por: Rodríguez-Castelán, Julia, et al.
Publicado: (2022)

Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)
por: Aceves, Carmen, et al.
Publicado: (2009)

Effects of Molecular Iodine/Chemotherapy in the Immune Component of Breast Cancer Tumoral Microenvironment
por: Cuenca-Micó, Olga, et al.
Publicado: (2021)

Preventive Effect of Molecular Iodine in Pancreatic Disorders from Hypothyroid Rabbits
por: Rodríguez-Castelán, Julia, et al.
Publicado: (2023)

SAT-561 Protective Effect of Moderated Dose of Iodine in Pancreatic Alterations during Hypothyroidism
por: Rodríguez-Castelán, Julia, et al.
Publicado: (2019)

Prostate gland as a target organ of thyroid hormones: advances and controversies
por: Anguiano, Brenda, et al.
Publicado: (2022)

Iodine a Preventive of Mammary Abscess
por: Stewart, H. C.
Publicado: (1853)

A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer
por: Arce, Claudia, et al.
Publicado: (2006)

Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

Doxorubicin as a Potential Treatment Option in Canine Mammary Tumors
por: Gherman, Madalina Luciana, et al.
Publicado: (2023)

Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
por: Wang, Congxiao, et al.
Publicado: (2022)

A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer
por: Arce, Claudia, et al.
Publicado: (2007)

Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin.
por: Vaage, J., et al.
Publicado: (1995)

Obese mammary tumour-bearing mice are highly sensitive to doxorubicin-induced hepatotoxicity
por: Sedeman, Megan, et al.
Publicado: (2022)

Mechanisms of Sodium/Iodide Symporter-Mediated Mammary Gland Iodine Compensation during Lactation
por: Fu, Min, et al.
Publicado: (2022)

Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
por: Trejo-Becerril, Catalina, et al.
Publicado: (2005)

Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients
por: URAKAWA, HIROSHI, et al.
Publicado: (2014)

Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma
por: Torrigiani, Filippo, et al.
Publicado: (2019)

Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for Different Subtypes of Patients With Breast Cancer
por: Wang, Ling-Cheng, et al.
Publicado: (2020)

Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with Ifosfamide-Doxorubicin for Osteosarcoma
por: Samimi, Mozhgan Aalam, et al.
Publicado: (2014)

Estudio comparativo de la lactancia materna exclusiva en la zona rural y urbana (colonia Poza de Cuero y comunidad La Guadalupe)
por: Silva Quiroz, Xochitl
Publicado: (1996)

Internal Mammary Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer
por: Bi, Zhao, et al.
Publicado: (2018)

Internal mammary lymph nodal response to neoadjuvant chemotherapy on imaging and breast cancer prognosis
por: Adam, Richard, et al.
Publicado: (2022)

Diseño de ductos y de aparejos de pozos productores de gas /
por: Perusquia Mendoza, Ignacio
Publicado: (1986)

Influencia del control prenatal sobre la morbimortalidad materna infantil. /
por: Montiel Perusquía, Jesús
Publicado: (2004)

La intolerancia religiosa en México y sus situaciones de hecho
por: Bocanegra Trejo, Jocelyn Eunice
Publicado: (2004)

Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
por: Salerno, Dominick, et al.
Publicado: (2021)

Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
por: Gorodnova, Tatiana V., et al.
Publicado: (2021)

Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines
por: Levi, Michela, et al.
Publicado: (2021)

Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma
por: Guil-Luna, Silvia, et al.
Publicado: (2014)

Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy
por: Cao, Xiao-Shan, et al.
Publicado: (2016)

Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors
por: Brandi, Andressa, et al.
Publicado: (2022)

Active Shiga-Like Toxin Produced by Some Aeromonas spp., Isolated in Mexico City
por: Palma-Martínez, Ingrid, et al.
Publicado: (2016)

Evaluation of Retail Meat as a Source of ESBL Escherichia coli in Tamaulipas, Mexico
por: Martínez-Vázquez, Ana Verónica, et al.
Publicado: (2022)

Iodine, Iodine metabolism and Iodine deficiency disorders revisited
por: Ahad, Farhana, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h8tig3nqgnck4hlb46enfips2i